SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 512.54 |
| Enterprise Value ($M) | 524.98 |
| Book Value ($M) | 256.29 |
| Book Value / Share | 2.32 |
| Price / Book | 2.00 |
| NCAV ($M) | 224.86 |
| NCAV / Share | 1.97 |
| Price / NCAV | 2.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.93 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.32 |
| Current Ratio | 5.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 296.47 |
| Assets | 327.90 |
| Liabilities | 71.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -275.94 |
| Net Income | -255.86 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -207.79 |
| Cash from Investing | 38.28 |
| Cash from Financing | 214.45 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Healthcare Capital Partners II, L.P. | 5.80 | -44.02 | |
| 13G/A | Point72 Asset Management, L.P. | 8.70 | -33.94 | |
| 13G | Paradigm Biocapital Advisors LP | 5.00 | ||
| 13G/A | Fmr Llc | 15.00 | 25.44 | |
| 13G/A | Commodore Capital Lp | 9.30 | 70.09 | |
| 13G/A | Kynam Capital Management, LP | 8.36 | 57.82 | |
| 13G/A | Suvretta Capital Management, Llc | 0.00 | -100.00 | |
| 13D/A | Fairmount Funds Management LLC | 9.90 | 13.45 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 285,433 | 667,585 | 42.76 | |
| 280,334 | 874,501 | 32.06 | |
| 155,656 | 738,821 | 21.07 | |
| 84,114 | 607,589 | 13.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGC – Canopy Growth Corporation | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. | COLL – Collegium Pharmaceutical, Inc. |
| CPIX – Cumberland Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io